Insiders · LBRX

LBRX insider transactions

LB Pharmaceuticals Inc (LBRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LBRX

• 2d
  SEC Form 4 filed by Director Ruffolo Robert R

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 2d
  SEC Form 4 filed by Director Nussbaum Ran

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 2d
  SEC Form 4 filed by Director Luse Rebecca

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 2d
  SEC Form 4 filed by Director Lenz Robert A.

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 2d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 2d
  SEC Form 4 filed by Director Kane William P Jr

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 2d
  SEC Form 4 filed by Director Garland J. Scott

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 89d
  SEC Form 4 filed by Director Lenz Robert A.

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 89d
  SEC Form 3 filed by new insider Lenz Robert A.

  3 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 117d
  SEC Form 4 filed by Large owner Deep Track Biotechnology Master Fund, Ltd.

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 178d
  SEC Form 4 filed by Chief Commercial Officer Pai Panandiker Kaya Kamlesh

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 201d
  SEC Form 3 filed by new insider Pai Panandiker Kaya Kamlesh

  3 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 251d
  SEC Form 4 filed by Senior Vice President, Finance Panoff Marc L

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 251d
  New insider Panoff Marc L claimed ownership of 10,242 shares (SEC Form 3)

  3 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 264d
  Large owner Deep Track Biotechnology Master Fund, Ltd. converted options into 686,138 shares and bought $39,999,990 worth of shares (2,666,666 units at $15.00) (SEC Form 4)

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 264d
  New insider Deep Track Special Opportunities Fund, Lp claimed ownership of 666,666 shares (SEC Form 3)

  3 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 264d
  Director Nussbaum Ran converted options into 411,681 shares and bought $15,000,000 worth of shares (1,000,000 units at $15.00) (SEC Form 4)

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 264d
  Large owner Pontifax Management 4 G.P. (2015) Ltd. bought $15,000,000 worth of shares (1,000,000 units at $15.00) and converted options into 411,681 shares (SEC Form 4)

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 264d
  Large owner Vida Ventures Gp Iii, L.L.C. converted options into 548,910 shares and bought $4,999,995 worth of shares (333,333 units at $15.00) (SEC Form 4)

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Director Luse Rebecca

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Director Kane William P Jr

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Director Ruffolo Robert R

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Director Prensky Zachary

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Chief Business Officer Soffer Gad

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Chief Executive Officer Turner Heather D

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Chief Medical Officer Eramo Anna

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Director Garland J. Scott

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by Director Nussbaum Ran

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)
• 268d
  SEC Form 4 filed by SVP, Technical Operations Silva Richard Anthony

  4 - LB PHARMACEUTICALS INC (0001691082) (Issuer)